Evidence map›Paper›PMID 34952827›Full record

Observational studyArchives of cardiovascular diseases2022

Care management and 90-day post discharge mortality in patients hospitalized for myocardial infarction and COVID-19: A French nationwide observational study.

Clémence Grave, Amélie Gabet, Jean-Philippe Empana, Etienne Puymirat, Philippe Tuppin, Nicolas Danchin, Valérie Olié

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Archives of cardiovascular diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Clémence GraveSanté Publique France (French Public Health Agency), 94415 Saint-Maurice, France. Electronic address: clemence.grave@santepubliquefrance.fr.
Amélie GabetSanté Publique France (French Public Health Agency), 94415 Saint-Maurice, France.
Jean-Philippe EmpanaInserm, UMR-S970, department of epidemiology, Paris Cardiovascular Research Centre, université Paris Descartes, 75015 Paris, France.
Etienne PuymiratDepartment of cardiology, hôpital Européen Georges-Pompidou, université Paris-Descartes, AP-HP, 75015 Paris, France.
Philippe TuppinCaisse Nationale de l'Assurance Maladie (French National Health Insurance), 75020 Paris, France.
Nicolas DanchinDepartment of cardiology, hôpital Européen Georges-Pompidou, université Paris-Descartes, AP-HP, 75015 Paris, France.
Valérie OliéSanté Publique France (French Public Health Agency), 94415 Saint-Maurice, France.
Santé Publique France · FRUniversité Paris Cité · FRInserm · FRl'Assurance Maladie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundConcomitant or cured coronavirus disease 2019 (COVID-19) in patients with myocardial infarction (MI) may lead to difficulties in acute care management and impair prognosis.

aimsTo describe and compare the characteristics, care management and 90-day post discharge outcomes of patients hospitalized for MI who did not have COVID-19 with those of patients with concomitant or previous hospital-diagnosed COVID-19.

methodsThis population-based French study included all patients hospitalized for MI in France (30 December 2019 to 04 October 2020) from the French National Health Data System. Outcomes were described for each COVID-19 group and compared using adjusted logistic regression analysis.

resultsAmong 55,524 patients hospitalized for MI, 135 had previous hospital-diagnosed COVID-19 and 329 had concomitant COVID-19. Patients with previous hospital-diagnosed COVID-19 had more personal history of cardiovascular diseases than those without concomitant/previous confirmed COVID-19. In-hospital and 90-day post discharge mortality rates of patients with previous COVID-19 were 8.1% and 4.0%, respectively, compared with 3.5% and 3.0% in patients without concomitant/previous confirmed COVID-19 (odds ratio [OR]

conclusionsIn-hospital and 90-day post discharge mortality of patients hospitalized for MI who had previous hospital-diagnosed COVID-19 did not seem to differ from those hospitalized for MI alone. Conversely, concomitant COVID-19 and MI carried a poorer prognosis extending beyond the hospital stay. Special attention should be given to patients with simultaneous COVID-19 and MI, in terms of acute care and secondary prevention.

Indexed as

COVID-19Myocardial InfarctionAftercareHospitalizationHospital MortalityHumansPatient DischargeSARS-CoV-2COVID-19Hospitalisation ;MortalitéHospitalizationInfarctus du myocardeMortalityMyocardial infarction

Identifiers

PMID34952827
PMCPMC8666304
OpenAlexW4200047913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.